[ESPR] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 0.87%
YoY- -5.52%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 145,419 184,474 0 0 0 0 0 -
PBT 87,379 -60,039 -49,911 -45,730 -46,130 -37,891 -45,219 -
Tax 0 -74 0 0 0 807 606 -
NP 87,379 -60,039 -49,911 -45,730 -46,130 -37,891 -45,219 -
Tax Rate 0.00% - - - - - - -
Total Cost 58,040 244,513 49,911 45,730 46,130 37,891 45,219 18.12%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 60.09 -32.55 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS 3.26 -2.24 -1.86 -1.71 -1.73 -1.44 -1.86 -
EPS Diluted 3.07 -2.24 -1.86 -1.71 -1.73 -1.44 -1.86 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.